EUVIMEDEUVIMED entdecken
Crossref

Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines

Merve Erkısa Genel, Selin Selvi, İsmail Yılmaz, Remzi Akar, İlhan Yaylım, Abdurrahman Şengül, Engin Ulukaya

Experimed · 2022

DOI: 10.26650/experimed.1188586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Merve Erkısa Genel und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Genel, M. E., Selvi, S., Yılmaz, İ., Akar, R., Yaylım, İ., Şengül, A., & Ulukaya, E. (2022). Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines. Experimed. https://doi.org/10.26650/experimed.1188586

Vancouver

Genel ME, Selvi S, Yılmaz İ, Akar R, Yaylım İ, Şengül A, et al. Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines. Experimed. 2022. doi:10.26650/experimed.1188586

BibTeX
@article{Genel2022,
  author = {Genel, Merve Erkısa and Selvi, Selin and Yılmaz, İsmail and Akar, Remzi and Yaylım, İlhan and Şengül, Abdurrahman and Ulukaya, Engin},
  title = {Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines},
  journal = {Experimed},
  year = {2022},
  doi = {10.26650/experimed.1188586}
}
Kostenlos starten →